Globant SA, in partnership with MIT Technology Review Insights, has released a new industry report titled "Transforming Commercial Pharma with Agentic AI," highlighting rapid adoption of agentic AI across the pharmaceutical sector. Based on a survey of 250 senior executives from nine countries, the study finds that three quarters of global pharma organizations are piloting or deploying agentic AI solutions. Early adopters are focusing on market intelligence, patient support, compliance, and data integration to capture over $100 billion in annual growth opportunities. The report emphasizes the importance of strong data foundations, with 84% of respondents prioritizing data standardization and integration. Industry leaders stress the need to embed agentic AI into core business processes, ensure compliance, and maintain clear human oversight for critical decision points.